Objective: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder increasingly recognized as an adult health concern. It is linked to behavioral disinhibitions that are studied to be associated with mental and physical health adversities, including obesity and hypertension, due to potential common genetic and environmental underpinnings. These connections remain underexplored, particularly in the Indian context. Hence, this study aims to explore the association of ADHD with obesity and hypertension among young adults in Delhi NCR, India.
Methods: This cross-sectional study involved 1537 participants aged 18-25 years residing in Delhi NCR, India. Sociodemographic data was collected via pretested and modified interview schedules. ADHD was screened using the ASRS v1.1 tool. Obesity was assessed in terms of general and central obesity using standard anthropometric measurements. Blood pressure was recorded using a digital sphygmomanometer.
Results: Combined-type ADHD correlated with a higher risk of central obesity, with 2.4-fold and 1.9-fold increased odds of high waist circumference (WC) and waist-height ratio (WHtR), respectively. The effect of ADHD on obesity intensified with age. No significant association was found with blood pressure, but trends suggested hypertension may escalate with age among ADHD individuals.
Conclusions: The study emphasizes the importance of incorporating ADHD diagnosis into obesity management programs and highlights the critical role of early, targeted interventions in effectively managing ADHD symptoms. Such an approach may help achieve better health outcomes and reduce the risk of future cardiovascular complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ajhb.70022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk of Serious Bacterial and Non-Bacterial Infections in People With MASLD.
Liver Int
April 2025
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common chronic liver disease globally. MASLD is a multisystem disease where metabolic dysfunction plays a key role in the development of MASLD and its most relevant liver-related morbidities and extrahepatic complications, such as cardiovascular disease, chronic kidney disease and certain types of extrahepatic cancers. Among the least examined MASLD-related extrahepatic complications, an ever-increasing number of observational studies have reported a positive association between MASLD and the risk of serious bacterial infections (SBI) requiring hospital admission.
View Article and Find Full Text PDFVitamin D receptor FokI polymorphism as a risk factor for painful diabetic neuropathy in type 2 diabetes mellitus patients.
J Neurogenet
March 2025
Department of Neurology, Faculty of Medicine, Universitas Udayana/Ngoerah Hospital, Bali, Indonesia.
Painful diabetic neuropathy (PDN) is a common complication in patients with type 2 diabetes mellitus (T2DM) with disruption of vitamin D (VD) activity as one of the risk factors. Active VD exerts its biological functions through the vitamin D receptor (VDR), which polymorphisms in the VDR gene can impair. This study aims to establish VDR FokI and ApaI polymorphisms as risk factors for PDN.
View Article and Find Full Text PDFMyeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction.
Circulation
March 2025
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL. (MF., Z.-D.G., M.D., C.L., K.G., S.E.W., E.B.T.).
Background: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment options remain limited. The HFpEF syndrome is associated with a high comorbidity burden, including high prevalence of obesity and hypertension. Although inflammation is implicated to play a key role in HFpEF pathophysiology, underlying causal mechanisms remain unclear.
View Article and Find Full Text PDFDifferent Modalities in the Management of Post-COVID-19 Olfactory Dysfunction.
Indian J Otolaryngol Head Neck Surg
January 2025
Otorhinolaryngology Department, Faculty of Medicine, Benha University, Benha, Qalyubia Egypt.
SARS-CoV-2 infection may lead to olfactory dysfunctions affecting patients' quality of life. Despite various ongoing studies, solid evidence supporting therapies, especially for COVID-19-related olfactory dysfunction, remains scarce. To assess nasal steroid, nasal vitamin A, and intranasal theophylline as treatment options for post-COVID-19 olfactory dysfunction.
View Article and Find Full Text PDFPrevalence and Correlates of Osteoporosis and Metabolic Syndrome Among Patients With Chronic Obstructive Pulmonary Disease at a Rural Tertiary Healthcare Center in India.
Cureus
February 2025
Department of Respiratory Medicine, Uttar Pradesh University of Medical Sciences, Etawah, IND.
Background Chronic obstructive pulmonary disease (COPD) results from chronic inflammation triggered by various risk factors. This inflammation can also impact other organ systems. COPD patients often have comorbidities such as osteoporosis and metabolic syndrome.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!